Drug recall · July 17, 2024
Diflorasone Diacetate Ointment recall
Why: Failed Impurities/Degradation Specifications: The impurity results at 12 months stability testing,did not conform to the specification limit.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., Brockton, MA 02301; Mfd. For: Rising Pharmaceuticals, Inc., East Brunswick, NJ 08816 NDC 64980-124-60
- Lots / codes
Lot #, DI2303B, Exp 12/31/2024
- Quantity
- 868 tubes
- Company
- Rising Pharma Holding, Inc., East Brunswick, NJ
- Distribution
- Nationwide in the USA
- Initiated
- June 24, 2024 · Voluntary: Firm initiated
- Classified
- July 16, 2024
- Reported
- July 17, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Diflorasone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.